Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients.
Horiuchi Y, Matsubayashi H, Kiyozumi Y, Nishimura S, Higashigawa S, Kado N, Nagashima T, Mizuguchi M, Ohnami S, Arai M, Urakami K, Kusuhara M, Yamaguchi K. Horiuchi Y, et al. Among authors: kado n. Hum Genet. 2021 Feb;140(2):321-331. doi: 10.1007/s00439-020-02207-6. Epub 2020 Jul 24. Hum Genet. 2021. PMID: 32710294
Role of Tumor Mutation Burden Analysis in Detecting Lynch Syndrome in Precision Medicine: Analysis of 2,501 Japanese Cancer Patients.
Kiyozumi Y, Matsubayashi H, Higashigawa S, Horiuchi Y, Kado N, Hirashima Y, Shiomi A, Oishi T, Ohnami S, Ohshima K, Urakami K, Nagashima T, Yamaguchi K. Kiyozumi Y, et al. Among authors: kado n. Cancer Epidemiol Biomarkers Prev. 2021 Jan;30(1):166-174. doi: 10.1158/1055-9965.EPI-20-0694. Epub 2020 Oct 12. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 33046448
Microsatellite instability is biased in Amsterdam II-defined Lynch-related cancer cases with family history but is rare in other cancers: a summary of 1000 analyses.
Matsubayashi H, Higashigawa S, Kiyozumi Y, Oishi T, Sasaki K, Ishiwatari H, Imai K, Hotta K, Yabuuchi Y, Ishikawa K, Satoh T, Ono H, Todaka A, Kawakami T, Shirasu H, Yasui H, Sugiura T, Uesaka K, Kagawa H, Shiomi A, Kado N, Hirashima Y, Kiyohara Y, Bando E, Niwakawa M, Nishimura S, Aramaki T, Mamesaya N, Kenmotsu H, Horiuchi Y, Serizawa M. Matsubayashi H, et al. Among authors: kado n. BMC Cancer. 2022 Jan 17;22(1):73. doi: 10.1186/s12885-022-09172-5. BMC Cancer. 2022. PMID: 35039004 Free PMC article.
Present status of germline findings in precision medicine for Japanese cancer patients: issues in the current system.
Higashigawa S, Matsubayashi H, Kiyozumi Y, Kado N, Nishimura S, Oishi T, Sugino T, Fushiki K, Shirasu H, Yasui H, Mamesaya N, Fukuzaki N, Kunitomo K, Horiuchi Y, Kenmotsu H, Serizawa M. Higashigawa S, et al. Among authors: kado n. Jpn J Clin Oncol. 2022 May 31;52(6):599-608. doi: 10.1093/jjco/hyac046. Jpn J Clin Oncol. 2022. PMID: 35411369
Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial.
Abe M, Hirashima Y, Kasamatsu Y, Kado N, Komeda S, Kuji S, Tanaka A, Takahashi N, Takekuma M, Hihara H, Ichikawa Y, Itonaga Y, Hirakawa T, Nasu K, Miyagi K, Murakami J, Ito K. Abe M, et al. Among authors: kado n. Support Care Cancer. 2016 Feb;24(2):675-682. doi: 10.1007/s00520-015-2829-z. Epub 2015 Jul 1. Support Care Cancer. 2016. PMID: 26130365 Clinical Trial.
86 results